跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
XYLOTIN 300 - LIDOCAINE HYDROCHLORIDE INJECTION USP 300MG/30ML - HSA Drug Approval Details
Approvals
/
HSA
/
XYLOTIN 300 - LIDOCAINE HYDROCHLORIDE INJECTION USP 300MG/30ML
Approved
THERAPEUTIC
XYLOTIN 300 - LIDOCAINE HYDROCHLORIDE INJECTION USP 300MG/30ML
ASPIRO PHARMA LIMITED (INDIA)
🇸🇬 Health Sciences Authority
Approval Date
Jun 12, 2020
Approval ID
bccfa097f09571cd
Company
ASPIRO PHARMA LIMITED (INDIA)
Type
Therapeutic
Approval Details
Approval Id
bccfa097f09571cd
Drug Name
XYLOTIN 300 - LIDOCAINE HYDROCHLORIDE INJECTION USP 300MG/30ML
Product Name
XYLOTIN 300 - LIDOCAINE HYDROCHLORIDE INJECTION USP 300MG/30ML
Approval Number
SIN15953P
Approval Date
2020-06-12
Registrant
HETERO SINGAPORE PTE. LTD.
Licence Holder
HETERO SINGAPORE PTE. LTD.
Drug Type
Therapeutic
Forensic Classification
PRESCRIPTION ONLY MEDICINES
Dosage Form
INJECTION, SOLUTION
Route Of Administration
INTRAVENOUS
Atc Code
N01BB02
Atc Item Name
lidocaine
Pharma Manufacturer Name
HETERO SINGAPORE PTE. LTD.
Company Detail Path
/organization/hetero-singapore-pte-ltd
Active Ingredients
Lidocaine Hydrochloride
300mg/30ml
LIDOCAINE HYDROCHLORIDE
300 MG/30 ML
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Jun 12, 2020
Approval ID
bccfa097f09571cd
Type
Therapeutic
Back to HSA Approvals